Jason Pesterfield

Mr. Pesterfield currently serves as CEO of Optellum Ltd, a provider of an imaging biomarker and AI-powered software that enables the early diagnosis and treatment of lung cancer. He has over 25 years of global medical device experience, most recently as CEO of Veran Medical, a provider of an electromagnetic navigation platform for the detection and treatment of lung cancer that was acquired by Olympus Medical in December 2020. Prior to that, he led Stryker Corporation’s Surgical Navigation Division where he was responsible for executing over 50 product launches, driving significant global growth, and escalating the company's market share and position under his tenure. Mr. Pesterfield specializes in raising growth capital, establishing high-performance cultures, and assembling talented cross-functional teams that develop and drive transformational technologies into sustainable high-growth, and high-valuation businesses. A seasoned healthcare technology executive, Mr. Pesterfield has significant expertise in developing innovative commercialization strategies to launch new medical technologies in the lung cancer space. He brings a network of industry contacts that will help Lumeda develop key relationships with medical thought leaders and commercial partners to accelerate the introduction and adoption of Lumeda’s novel technology. A graduate of the University of Nebraska, Jason was a scholarship student-athlete of the Nebraska football team that won numerous titles including the NCAA national championship in 1994.